Risk Register (RAG)

Quantified risk governance with inherent vs residual scoring (Probability × Impact), aligned to brownfield sterile biologics expansion delivery.

Risk Governance P×I Scoring Residual Risk Inspection Readiness

Scoring Model

Risks are scored using a 1–5 scale for Probability (P) and Impact (I). Inherent risk reflects the pre-mitigation exposure. Residual risk reflects expected exposure after mitigation and controls. Scores are reviewed on cadence and escalated through Steering if residual exposure remains high.

Measure Scale Examples (Context)
Probability (P) 1–5 Rare (1) → Almost Certain (5)
Impact (I) 1–5 Minimal (1) → Critical (5) across compliance, schedule, cost, supply continuity
Score P × I (1–25) Used for prioritisation and governance intensity
RAG Thresholds Green 1–6   ·   Amber 7–12   ·   Red 13–25

Risk Register

Tip: On mobile, scroll the table horizontally. The header is sticky (if you added the CSS enhancement), and the first columns are sticky on desktop for faster review.

ID Risk Statement Category Owner P I Inherent Mitigation / Controls Trigger / Early Warning Contingency Residual Residual RAG Due / Review Status
R1 Vendor bioreactor FAT failure (weld integrity / surface finish) delays delivery and compresses installation & validation windows. Supply Chain / Technical Engineering Lead 4 5 20 Enhanced vendor quality plan, QA witness points, early doc review, contractual escalation and rework thresholds. NCR trend, delayed FAT pack, repeated rework cycles, weld map deviations beyond tolerance. Parallel rework approval route; resequence HVAC/automation work; preserve CQV critical path; alternate fabrication slot (pre-agreed). 12 Amber Monthly until FAT complete Active
R2 Utilities load overcapacity (WFI / clean steam / HVAC) causes revalidation failure or unplanned scope increase. Operational / Technical Utilities Lead 3 5 15 Early load modelling (±5% margin), staged commissioning, validated boundary isolation plan, QA review of test acceptance criteria. Capacity excursions, unstable pressure cascades, repeated alarms during SAT, HVAC balancing drift. Temporary capacity solutions; controlled downtime windows; modular utility add-ons; scope switch approvals via CCB. 9 Amber Biweekly during commissioning Active
R3 Cleanroom ISO classification fails at handover due to airflow patterns, leakage paths, particle counts or differential pressure instability. Quality / Operational Construction PM 3 5 15 Progressive room readiness checks, strict penetration control, smoke studies early, staged certification, contractor quality gates. Rework on seals/penetrations, particle count excursions, airflow imbalance, cascade not holding during trials. Extended balancing window, specialist commissioning support, temporary operating restrictions, controlled rework sprints. 10 Amber Weekly during cleanroom completion Active
R4 EU GMP Annex 1 interpretation changes introduce additional contamination control requirements after design freeze. Regulatory / Quality QA Lead 3 4 12 Quality-led design checkpoints, CCS alignment workshops, maintain inspection file with rationale & traceability. Emerging industry findings, HPRA feedback themes, CCS narrative gaps, audit observation trends. Rapid gap remediation plan; targeted retrofit scope; pre-approved minor layout adjustments and SOP updates. 6 Green Monthly until inspection Active
R5 CSV gaps (audit trails, access controls, Part 11 evidence) delay validation release for automation and batch records. Quality / Digital Automation Lead 4 4 16 Approved validation plan, supplier assessment, scripted OQ aligned to URS, security matrix and DI review gates. Late requirements changes, missing vendor test packs, unresolved deviations, incomplete security roles. Specialist CSV contractors; phased system release; temporary manual controls with QA; expedited deviation review. 9 Amber Weekly during OQ/PQ Active
R6 Vendor documentation incomplete (MTRs, calibration certs, manuals) blocks IQ approval and delays CQV closeout. Supply Chain / Quality CQV Lead 4 3 12 Doc readiness tracker with due dates, enforce contractual deliverables, document review sprints with vendors. Late doc pack, repeated review cycles, missing traceability to tags, incomplete as-built drawings. Conditional IQ acceptance with defined closures; substitute evidence pathway; procurement escalation for leverage. 8 Amber Weekly until IQ closeout Active
R7 Brownfield tie-in works impact live production (planned downtime overruns or contamination risk at interface points). Operational Site Ops Lead 3 5 15 Permit-to-work, isolation plans, QA oversight at interfaces, rehearsed cutover steps, shift-based execution windows. Isolation gaps, access constraints, abnormal alarms in live utilities, near-miss incident reports. Rollback plan with predefined stop points; buffer inventory; move tie-in to next approved window. 6 Green Per tie-in window Active
R8 Environmental monitoring baseline shifts post-build drive OOS/OOT trends during PQ and ramp-up. Quality Microbiology Lead 3 4 12 Progressive EM mapping, cleaning validation tightening, routine trend reviews during PQ, targeted intervention minimisation. Recurring excursion points, rising particle counts, increased interventions during media fills/simulations. Targeted remediation (airflow, cleaning SOPs), extended EM studies, adjust operational controls with QA approval. 8 Amber Weekly during PQ Active
R9 Data integrity gaps in controlled documents (versioning, sign-off traceability) weaken inspection readiness and governance confidence. Quality / Compliance Quality Systems Lead 3 5 15 Single source of truth repository, document readiness index, periodic internal audits, inspection file ownership. Uncontrolled copies, missing approvals, conflicting versions, delayed doc reconciliation. Remediation sprint; temporary freeze on issuing new docs until reconciled; structured back-capture and audit trail review. 6 Green Biweekly until inspection Active
R10 Inspection booking changes or unexpected inspection scope expansion reduces available closure window before go-live. Regulatory Regulatory Liaison 2 5 10 Pre-inspection engagement cadence, readiness evidence packs, SME roster and audit room protocols confirmed early. Changed inspector availability, additional requested evidence sets, increased pre-reads, new focus areas. Rapid response documentation sprint; extend SME coverage; prioritise closure of critical systems first. 6 Green Monthly until inspection Active
R11 Validation deviation volume increases during late-stage execution, creating approval bottlenecks and CQV rework. Quality / Delivery CQV Lead 4 3 12 Deviation triage, standard impact templates, weekly review cadence, clear closure ownership and due dates. Backlog trend rising, repeated re-submissions, unclear impact ratings, late evidence uploads. Increase review frequency; dedicate reviewers; “fast-track” low-risk deviations; temporary weekend review cadence. 8 Amber Weekly during peak CQV Active
R12 CCB volume spikes during execution cause late design changes and schedule churn, impacting readiness gates. Governance PMO Lead 4 3 12 Change freeze windows, triage board, delegated approval tiers, standardised impact assessment for GMP/schedule/cost. CCB backlog, unclear GMP impacts, repeated resubmissions, late change requests after design freeze. Increase CCB cadence; temporary approval delegation; “fast lane” for low-risk changes; re-baseline with exec sign-off. 6 Green Weekly during peak changes Active
R13 Commissioning completion slips due to contractor sequencing conflicts (HVAC / electrical / instrumentation) delaying IQ start. Schedule / Delivery Construction PM 3 4 12 Daily look-ahead planning, interface matrix, locked handover checklists, readiness gates per system. High rework rates, missed handover criteria, incomplete punch lists, repeated access conflicts. Deploy additional supervisors; restructure sequencing; weekend shifts; re-baseline handover dates with CQV priorities. 8 Amber Weekly during commissioning Active
R14 Supply continuity buffer becomes insufficient if ramp-up is delayed, increasing customer allocation and service risk. Commercial / Operational Supply Chain Lead 3 4 12 Ramp-up plan with staged capacity release; inventory policy review; coordination with network sites and QP planning. PQ closure delays, constrained batch release, forecast variance increase, rise in expedite requests. Activate alternate site support; prioritise markets; extend safety stock through controlled overtime and scheduling. 8 Amber Monthly during ramp-up Active
R15 Qualified Person (QP) release readiness lag (documentation completeness, closure evidence) delays commercial release decision. Quality / Release QA Lead 3 5 15 QP readiness checklist, weekly closure reviews, doc readiness index linked to release gate, pre-review of key evidence sets. Missing approvals, incomplete deviation closures, delayed EM trend reports, unresolved open actions. Release readiness sprint; dedicated reviewers; prioritised evidence closures; escalate for targeted decision support. 9 Amber Weekly during PQ closeout Active

Residual Risk Escalation Rule